purchase customization

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Rare Disease Genetic Testing
1.2 Key Market Segments
1.2.1 Rare Disease Genetic Testing Segment by Type
1.2.2 Rare Disease Genetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Rare Disease Genetic Testing Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Rare Disease Genetic Testing Market Competitive Landscape
3.1 Global Rare Disease Genetic Testing Revenue Market Share by Company (2019-2024)
3.2 Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Rare Disease Genetic Testing Market Size Sites, Area Served, Product Type
3.4 Rare Disease Genetic Testing Market Competitive Situation and Trends
3.4.1 Rare Disease Genetic Testing Market Concentration Rate
3.4.2 Global 5 and 10 Largest Rare Disease Genetic Testing Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Rare Disease Genetic Testing Value Chain Analysis
4.1 Rare Disease Genetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Rare Disease Genetic Testing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Rare Disease Genetic Testing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rare Disease Genetic Testing Market Size Market Share by Type (2019-2024)
6.3 Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2019-2024)
7 Rare Disease Genetic Testing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rare Disease Genetic Testing Market Size (M USD) by Application (2019-2024)
7.3 Global Rare Disease Genetic Testing Market Size Growth Rate by Application (2019-2024)
8 Rare Disease Genetic Testing Market Segmentation by Region
8.1 Global Rare Disease Genetic Testing Market Size by Region
8.1.1 Global Rare Disease Genetic Testing Market Size by Region
8.1.2 Global Rare Disease Genetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Rare Disease Genetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Rare Disease Genetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Rare Disease Genetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Rare Disease Genetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Rare Disease Genetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Quest Diagnostics
9.1.1 Quest Diagnostics Rare Disease Genetic Testing Basic Information
9.1.2 Quest Diagnostics Rare Disease Genetic Testing Product Overview
9.1.3 Quest Diagnostics Rare Disease Genetic Testing Product Market Performance
9.1.4 Quest Diagnostics Rare Disease Genetic Testing SWOT Analysis
9.1.5 Quest Diagnostics Business Overview
9.1.6 Quest Diagnostics Recent Developments
9.2 Centogene
9.2.1 Centogene Rare Disease Genetic Testing Basic Information
9.2.2 Centogene Rare Disease Genetic Testing Product Overview
9.2.3 Centogene Rare Disease Genetic Testing Product Market Performance
9.2.4 Quest Diagnostics Rare Disease Genetic Testing SWOT Analysis
9.2.5 Centogene Business Overview
9.2.6 Centogene Recent Developments
9.3 Invitae Corporation
9.3.1 Invitae Corporation Rare Disease Genetic Testing Basic Information
9.3.2 Invitae Corporation Rare Disease Genetic Testing Product Overview
9.3.3 Invitae Corporation Rare Disease Genetic Testing Product Market Performance
9.3.4 Quest Diagnostics Rare Disease Genetic Testing SWOT Analysis
9.3.5 Invitae Corporation Business Overview
9.3.6 Invitae Corporation Recent Developments
9.4 3billion
9.4.1 3billion Rare Disease Genetic Testing Basic Information
9.4.2 3billion Rare Disease Genetic Testing Product Overview
9.4.3 3billion Rare Disease Genetic Testing Product Market Performance
9.4.4 3billion Business Overview
9.4.5 3billion Recent Developments
9.5 Arup Laboratories
9.5.1 Arup Laboratories Rare Disease Genetic Testing Basic Information
9.5.2 Arup Laboratories Rare Disease Genetic Testing Product Overview
9.5.3 Arup Laboratories Rare Disease Genetic Testing Product Market Performance
9.5.4 Arup Laboratories Business Overview
9.5.5 Arup Laboratories Recent Developments
9.6 Eurofins Scientific
9.6.1 Eurofins Scientific Rare Disease Genetic Testing Basic Information
9.6.2 Eurofins Scientific Rare Disease Genetic Testing Product Overview
9.6.3 Eurofins Scientific Rare Disease Genetic Testing Product Market Performance
9.6.4 Eurofins Scientific Business Overview
9.6.5 Eurofins Scientific Recent Developments
9.7 Strand Life Sciences
9.7.1 Strand Life Sciences Rare Disease Genetic Testing Basic Information
9.7.2 Strand Life Sciences Rare Disease Genetic Testing Product Overview
9.7.3 Strand Life Sciences Rare Disease Genetic Testing Product Market Performance
9.7.4 Strand Life Sciences Business Overview
9.7.5 Strand Life Sciences Recent Developments
9.8 Ambry Genetics
9.8.1 Ambry Genetics Rare Disease Genetic Testing Basic Information
9.8.2 Ambry Genetics Rare Disease Genetic Testing Product Overview
9.8.3 Ambry Genetics Rare Disease Genetic Testing Product Market Performance
9.8.4 Ambry Genetics Business Overview
9.8.5 Ambry Genetics Recent Developments
9.9 Perkin Elmer
9.9.1 Perkin Elmer Rare Disease Genetic Testing Basic Information
9.9.2 Perkin Elmer Rare Disease Genetic Testing Product Overview
9.9.3 Perkin Elmer Rare Disease Genetic Testing Product Market Performance
9.9.4 Perkin Elmer Business Overview
9.9.5 Perkin Elmer Recent Developments
9.10 Macrogen
9.10.1 Macrogen Rare Disease Genetic Testing Basic Information
9.10.2 Macrogen Rare Disease Genetic Testing Product Overview
9.10.3 Macrogen Rare Disease Genetic Testing Product Market Performance
9.10.4 Macrogen Business Overview
9.10.5 Macrogen Recent Developments
9.11 Baylor Genetics
9.11.1 Baylor Genetics Rare Disease Genetic Testing Basic Information
9.11.2 Baylor Genetics Rare Disease Genetic Testing Product Overview
9.11.3 Baylor Genetics Rare Disease Genetic Testing Product Market Performance
9.11.4 Baylor Genetics Business Overview
9.11.5 Baylor Genetics Recent Developments
9.12 Color Genomics
9.12.1 Color Genomics Rare Disease Genetic Testing Basic Information
9.12.2 Color Genomics Rare Disease Genetic Testing Product Overview
9.12.3 Color Genomics Rare Disease Genetic Testing Product Market Performance
9.12.4 Color Genomics Business Overview
9.12.5 Color Genomics Recent Developments
9.13 Preventiongenetics
9.13.1 Preventiongenetics Rare Disease Genetic Testing Basic Information
9.13.2 Preventiongenetics Rare Disease Genetic Testing Product Overview
9.13.3 Preventiongenetics Rare Disease Genetic Testing Product Market Performance
9.13.4 Preventiongenetics Business Overview
9.13.5 Preventiongenetics Recent Developments
9.14 Progenity
9.14.1 Progenity Rare Disease Genetic Testing Basic Information
9.14.2 Progenity Rare Disease Genetic Testing Product Overview
9.14.3 Progenity Rare Disease Genetic Testing Product Market Performance
9.14.4 Progenity Business Overview
9.14.5 Progenity Recent Developments
9.15 Coopersurgical
9.15.1 Coopersurgical Rare Disease Genetic Testing Basic Information
9.15.2 Coopersurgical Rare Disease Genetic Testing Product Overview
9.15.3 Coopersurgical Rare Disease Genetic Testing Product Market Performance
9.15.4 Coopersurgical Business Overview
9.15.5 Coopersurgical Recent Developments
9.16 Fulgent Genetics
9.16.1 Fulgent Genetics Rare Disease Genetic Testing Basic Information
9.16.2 Fulgent Genetics Rare Disease Genetic Testing Product Overview
9.16.3 Fulgent Genetics Rare Disease Genetic Testing Product Market Performance
9.16.4 Fulgent Genetics Business Overview
9.16.5 Fulgent Genetics Recent Developments
9.17 Myriad Genetics
9.17.1 Myriad Genetics Rare Disease Genetic Testing Basic Information
9.17.2 Myriad Genetics Rare Disease Genetic Testing Product Overview
9.17.3 Myriad Genetics Rare Disease Genetic Testing Product Market Performance
9.17.4 Myriad Genetics Business Overview
9.17.5 Myriad Genetics Recent Developments
9.18 LabCorp
9.18.1 LabCorp Rare Disease Genetic Testing Basic Information
9.18.2 LabCorp Rare Disease Genetic Testing Product Overview
9.18.3 LabCorp Rare Disease Genetic Testing Product Market Performance
9.18.4 LabCorp Business Overview
9.18.5 LabCorp Recent Developments
9.19 Opko Health
9.19.1 Opko Health Rare Disease Genetic Testing Basic Information
9.19.2 Opko Health Rare Disease Genetic Testing Product Overview
9.19.3 Opko Health Rare Disease Genetic Testing Product Market Performance
9.19.4 Opko Health Business Overview
9.19.5 Opko Health Recent Developments
10 Rare Disease Genetic Testing Regional Market Forecast
10.1 Global Rare Disease Genetic Testing Market Size Forecast
10.2 Global Rare Disease Genetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Rare Disease Genetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Rare Disease Genetic Testing Market Size Forecast by Region
10.2.4 South America Rare Disease Genetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Rare Disease Genetic Testing by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Rare Disease Genetic Testing Market Forecast by Type (2025-2030)
11.2 Global Rare Disease Genetic Testing Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings